MYNZ
Mainz Biomed NV
NASDAQ · Healthcare · Medical - Diagnostics & Research · DE
$3.59
+0.84%Leverage
- Debt / equity
- 1.23x
- Net debt / equity
- 0.47x
- Debt / assets
- 0.32x
- Debt / EBITDA
- -0.19x
- Net debt / EBITDA
- -0.07x
Liquidity & coverage
- Current ratio
- 0.52x
- Quick ratio
- 0.43x
- Cash ratio
- 0.32x
- Interest coverage
- -43.22x
- EBITDA / interest
- -43.22x
- Working capital
- -$2.9M
Cash & dividend
- FCF / debt
- -3.55x
- Cash flow / debt
- -3.55x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Dec 1, 2025